| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/12/2013 | CN103142519A Levocarnitine tablets and preparation method thereof |
| 06/12/2013 | CN102440973B Diphenhydramine citrate orally disintegrating tablet and preparation method thereof |
| 06/12/2013 | CN102379843B Levocarnitine pharmaceutical composition for injection |
| 06/12/2013 | CN102048825B Nux vomica capsules for treating myasthenia gravis and preparation process thereof |
| 06/12/2013 | CN101863917B Methocarbamol salt |
| 06/11/2013 | CA2484209C Protein kinase modulators and methods of use |
| 06/11/2013 | CA2407959C Human wingless-like gene |
| 06/06/2013 | WO2013081118A1 Compound having read-through activity |
| 06/06/2013 | WO2013081094A1 Imidazo[1,2-a]pyridine derivative and use thereof for medical purposes |
| 06/06/2013 | WO2013079487A1 Pharmaceutical composition for use in the treatment of dysfunction associated with aging |
| 06/06/2013 | US20130143845 Vitamin d compounds and methods for enhancing muscle strength, and prevention and treatment of disease in human beings |
| 06/05/2013 | EP2599868A1 NUCLEIC ACID MOLECULE CAPABLE OF BINDING TO c-Met AND USE THEREOF |
| 06/05/2013 | EP2599771A1 Naphthalene derivative |
| 06/05/2013 | EP2598517A1 Modulators of protease activated receptors |
| 06/05/2013 | CN103130828A Methocarbamol diammonium phosphate, and polymorphism and preparation method thereof |
| 06/05/2013 | CN103130684A Polymorphism of methocarbamol dipotassium phosphate and preparation method thereof |
| 06/05/2013 | CN103130683A Polymorphism of methocarbamol dihydric phosphate and preparation method thereof |
| 06/05/2013 | CN103127550A Skeletal muscle whole organ acellular matrix, its preparation method and its derived medical products |
| 06/05/2013 | CN103127300A Chinese medicinal composition for fumigation treatment of lumbar disc herniation |
| 06/05/2013 | CN103127024A Stable disodium adenosine triphosphate tablet |
| 06/05/2013 | CN103126971A Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins |
| 06/05/2013 | CN102335326B Chinese medicinal composition for invigorating circulation of blood to dissipate blood stasis and reducing swelling and relieving pain |
| 06/05/2013 | CN101528214B Substituted acylanilides and methods of use thereof |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455448 Myostatin isoform |
| 06/04/2013 | US8455445 Methods for inhibiting lymphotoxin-β receptor signaling in TH1 cell-associated disorders |
| 05/30/2013 | WO2013078261A1 Treatment of muscular conditions and muscular dystrophies |
| 05/29/2013 | EP2595663A2 Modulation of dystrophia myotonica-protein kinase (dmpk) expression |
| 05/29/2013 | EP2595624A2 Adverse side-effects associated with administration of an anti-hyaluronan agent and methods for ameliorating or preventing the side-effects |
| 05/29/2013 | CN1911965B Binding domain-immunoglobulin fusion proteins |
| 05/29/2013 | CN103120655A Composition for amelioration/prevention of adverse side effect in steroid therapy |
| 05/29/2013 | CN101538218B Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2455100C Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 05/23/2013 | WO2013074636A1 Muscle specific receptor kinase and modulation thereof |
| 05/23/2013 | WO2013074557A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a |
| 05/23/2013 | US20130133092 Sequence-specific dna recombination in eukaryotic cells |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2855822A1 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and/or activin a |
| 05/22/2013 | EP2594642A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2594641A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2594640A1 Induction of exon skipping in eukaryotic cells |
| 05/22/2013 | EP2593109A1 Method and formulations for treating sialic acid deficiencies |
| 05/22/2013 | CN103119043A Fused heterocyclic compound and application thereof |
| 05/22/2013 | CN103118694A Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-tRNA synthetases |
| 05/22/2013 | CN103118685A Drug against central nervous system inflammation |
| 05/22/2013 | CN103110817A Traditional Chinese medicine for treating diseases caused by spinal lesions |
| 05/22/2013 | CN103110716A Bone-knitting traditional Chinese medicine |
| 05/22/2013 | CN103110602A Disodium adenosine triphosphate troche medical composition |
| 05/22/2013 | CN103110582A Cannabinol compound micro-emulsion and preparation method thereof |
| 05/22/2013 | CN101862331B New use of methyl liensinine |
| 05/22/2013 | CN101849006B Improved antibody molecule |
| 05/22/2013 | CN101678047B Remedy and diagnostic agent for mitochondrial dysfunction brain disease |
| 05/21/2013 | US8445660 Chimeric vaccines |
| 05/16/2013 | WO2013067639A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
| 05/16/2013 | WO2013067591A1 Topical formulations for pain management |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130122105 Methods and Compositions for Gene Therapy and GHRH Therapy |
| 05/16/2013 | US20130121974 Methods of making enhanced, autologous fat grafts |
| 05/16/2013 | CA2854372A1 Use of rank/rankl antagonists for treating neuromuscular disorders, genetic myopathies and/or non genetic myopathies and/or for regulating skeletal and cardiac muscle disuse, diseases and aging |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2590936A2 Phenylcarbamate compound and muscle relaxant containing the same |
| 05/15/2013 | EP2590661A1 Improved method for stem cell differentiation in vivo by delivery of morphogenes with mesoporous silica and corresponding pharmaceutical active ingredients. |
| 05/15/2013 | EP2590521A1 Nutritional composition for the stimulation of muscle protein synthesis |
| 05/15/2013 | CN103102359A Pyrimidine compounds and application thereof |
| 05/15/2013 | CN103102349A Protein kinase inhibitor and composition and application thereof |
| 05/15/2013 | CN103099926A Externally used traditional Chinese medicine (TCM) preparation for treating vertebral artery type cervical spondylopathy |
| 05/15/2013 | CN103099876A Tablets for tonifying qi and promoting yang |
| 05/15/2013 | CN103099856A White paeony root processed product and preparation method thereof |
| 05/15/2013 | CN102309475B Levocarnitine for injection and preparation method thereof |
| 05/15/2013 | CN101744285B Method for preparing emulsified and gelatinized functional fatty acid carrier |
| 05/14/2013 | US8440204 Subtype of Closteridium botulinum neurotoxin type A and uses thereof |
| 05/14/2013 | US8440189 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 05/14/2013 | CA2434303C Method for obtaining a tgf-beta enriched protein fraction in activated form, protein fraction and therapeutic applications |
| 05/10/2013 | WO2013064585A1 Treatment of musculoskeletal fibroproliferative disorders |
| 05/09/2013 | US20130116268 Use of modified pyrimidine compounds to promote stem cell migration and proliferation |
| 05/08/2013 | EP2588610A1 Calpain-3 inhibitors for treating muscular dystrophies and cardiomyopathies |
| 05/08/2013 | CN103097519A Somatic stem cells |
| 05/08/2013 | CN103097415A Humanised antigen binding proteins to myostatin6 |
| 05/08/2013 | CN103096928A Prophylactic or ameliorating agent for genetic diseases |
| 05/08/2013 | CN103087066A Haloaryl Substituted Aminopurines, Compositions Thereof, And Methods Of Treatment Therewith |
| 05/08/2013 | CN103086936A Aryl compounds as PPAR ligands and their use |
| 05/08/2013 | CN103083740A Method for treating joint disease and skin disease by utilizing Chinese medicine acupuncture and cupping technology |
| 05/08/2013 | CN103083669A Method for treatment of inflammatory disease and disorder |
| 05/08/2013 | CN103083564A Preparation method for dermatomyositis treatment traditional Chinese medicine preparation |
| 05/08/2013 | CN103083458A Warm light drink compound formula granule, as well as preparation method as well as detection method thereof |
| 05/08/2013 | CN103083450A Traditional Chinese medicine for treating stiff neck |
| 05/08/2013 | CN101801907B Compounds isolated from antrodia cinnamomea and use thereof |
| 05/08/2013 | CN101534804B Transnasal anticonvulsive pharmaceutical composition |
| 05/07/2013 | US8435945 GH secretagogues and uses thereof |
| 05/02/2013 | WO2013063536A1 Actriib binding agents and uses thereof |
| 05/02/2013 | US20130109755 Baclofen Formulations and Methods for Making Same |
| 05/02/2013 | US20130109624 Novel neurotrophic factors |
| 05/02/2013 | US20130108650 Actriib binding agents and uses thereof |
| 05/01/2013 | EP2586798A2 B-cell reduction using CD37-specific and CD20-specific binding molecules |
| 05/01/2013 | EP2586462A1 Prophylactic or ameliorating agent for genetic diseases |
| 05/01/2013 | EP2586441A1 Combination of egcg or methylated egcg and a pde inhibitor |
| 05/01/2013 | EP2585171A1 Formation of neuromuscular junctions in a defined system |